title: Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential.
abstract: The involvement of 12-lipoxygenase (12-LOX) expression and function in tumor metastasis has been demonstrated in several murine tumor cell lines. In addition, 12-LOX expression was detected in human prostatic tumors and correlated to the clinical stage of disease. Here we provide data that human prostate cancer cell lines express the platelet-type isoform of 12-LOX at both the mRNA and protein levels, and immunohistochemistry revealed 12-LOX expression in human prostate tumors. The enzyme was localized to the plasma membrane, cytoplasmic organelles and nucleus in non-metastatic cells (PC-3 nm) and to the cytoskeleton and nucleus in metastatic cells (DU-145). After orthotopic/intraprostatic injection of tumor cells into SCID mice, the metastatic prostate carcinoma cells (DU-145) expressed 12-LOX at a significantly higher level compared with the non-metastatic counterparts, PC-3nm. The functional involvement of 12-LOX in the metastatic process was demonstrated when DU-145 cells were pretreated in vitro with the 12-LOX inhibitors N-benzyl-N-hydroxy-5-phenylpentamide (BHPP) or baicalein, the use of which significantly inhibited lung colonization. These data suggest a potential involvement of 12-LOX in the progression of human prostate cancer.
authors.affiliation: Department of Tumor Progression, National Institute of Oncology, Budapest, Hungary. jtimar@oncol.hu
authors.forename: J
authors.initials: J
authors.lastname: Timár
authors.forename: E
authors.initials: E
authors.lastname: Rásó
authors.forename: B
authors.initials: B
authors.lastname: Döme
authors.forename: L
authors.initials: L
authors.lastname: Li
authors.forename: D
authors.initials: D
authors.lastname: Grignon
authors.forename: D
authors.initials: D
authors.lastname: Nie
authors.forename: K V
authors.initials: KV
authors.lastname: Honn
authors.forename: W
authors.initials: W
authors.lastname: Hagmann
mesh_terms: D000818:Animals; D001092:Arachidonate 12-Lipoxygenase / Q000096:biosynthesis* / Q000502:physiology*; D001792:Blood Platelets / Q000201:enzymology*; D002462:Cell Membrane / Q000201:enzymology; D003593:Cytoplasm / Q000201:enzymology; D003599:Cytoskeleton / Q000201:enzymology; D018450:Disease Progression; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry; D016859:Lipoxygenase Inhibitors; D008297:Male; D051379:Mice; D016513:Mice, SCID; D018613:Microscopy, Confocal; D009361:Neoplasm Invasiveness; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D010641:Phenotype; D011471:Prostatic Neoplasms / Q000201:enzymology* / Q000473:pathology; D020033:Protein Isoforms; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured
chemical_list: D016859:Lipoxygenase Inhibitors; D020033:Protein Isoforms; D012333:RNA, Messenger; D001092:Arachidonate 12-Lipoxygenase